Global Tadalafil Oral Market Growth 2025-2031
The global Tadalafil Oral market size is predicted to grow from US$ 137 million in 2025 to US$ 170 million in 2031; it is expected to grow at a CAGR of 3.7% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Tadalafil (INN) is a PDE5 inhibitor marketed in pill form for treating erectile dysfunction (ED).
Tadalafil oral is a medication used to treat erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). It is marketed under various brand names, including Cialis. Tadalafil belongs to a class of drugs called phosphodiesterase type 5 inhibitors (PDE5 inhibitors), which work by increasing blood flow to the penis, helping men achieve and maintain an erection. Market trends for tadalafil can vary over time and across regions. Factors such as the introduction of generic versions, changes in pricing, competition from other ED medications, and consumer preferences can influence market dynamics. According to recent market research reports, the global tadalafil oral market is expected to grow due to increasing cases of erectile dysfunction and benign prostatic hyperplasia among the aging population, as well as growing awareness and healthcare expenditure for these conditions. Additionally, the availability of various formulation types and convenience in purchasing medication online are expected to drive market growth.
LP Information, Inc. (LPI) ' newest research report, the “Tadalafil Oral Industry Forecast” looks at past sales and reviews total world Tadalafil Oral sales in 2024, providing a comprehensive analysis by region and market sector of projected Tadalafil Oral sales for 2025 through 2031. With Tadalafil Oral sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tadalafil Oral industry.
This Insight Report provides a comprehensive analysis of the global Tadalafil Oral landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tadalafil Oral portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tadalafil Oral market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tadalafil Oral and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tadalafil Oral.
This report presents a comprehensive overview, market shares, and growth opportunities of Tadalafil Oral market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Tadalafil Oral market?
What factors are driving Tadalafil Oral market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tadalafil Oral market opportunities vary by end market size?
How does Tadalafil Oral break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Tadalafil (INN) is a PDE5 inhibitor marketed in pill form for treating erectile dysfunction (ED).
Tadalafil oral is a medication used to treat erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). It is marketed under various brand names, including Cialis. Tadalafil belongs to a class of drugs called phosphodiesterase type 5 inhibitors (PDE5 inhibitors), which work by increasing blood flow to the penis, helping men achieve and maintain an erection. Market trends for tadalafil can vary over time and across regions. Factors such as the introduction of generic versions, changes in pricing, competition from other ED medications, and consumer preferences can influence market dynamics. According to recent market research reports, the global tadalafil oral market is expected to grow due to increasing cases of erectile dysfunction and benign prostatic hyperplasia among the aging population, as well as growing awareness and healthcare expenditure for these conditions. Additionally, the availability of various formulation types and convenience in purchasing medication online are expected to drive market growth.
LP Information, Inc. (LPI) ' newest research report, the “Tadalafil Oral Industry Forecast” looks at past sales and reviews total world Tadalafil Oral sales in 2024, providing a comprehensive analysis by region and market sector of projected Tadalafil Oral sales for 2025 through 2031. With Tadalafil Oral sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tadalafil Oral industry.
This Insight Report provides a comprehensive analysis of the global Tadalafil Oral landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tadalafil Oral portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tadalafil Oral market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tadalafil Oral and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tadalafil Oral.
This report presents a comprehensive overview, market shares, and growth opportunities of Tadalafil Oral market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 2.5 mg tablets
- 5 mg tablets
- 10mg tablets
- 20 mg tablets
- Hospital
- Drug store
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eli Lilly
- Teva
- Aurobindo
- Sun Pharma
- Alembic Pharmaceuticals
- Mylan
- Cipla
- Ajanta Pharma Ltd.
- Dr. Reddys Laboratories
- Qilu Pharmaceutical
What is the 10-year outlook for the global Tadalafil Oral market?
What factors are driving Tadalafil Oral market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tadalafil Oral market opportunities vary by end market size?
How does Tadalafil Oral break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tadalafil Oral Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Tadalafil Oral by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Tadalafil Oral by Country/Region, 2020, 2024 & 2031
2.2 Tadalafil Oral Segment by Type
2.2.1 2.5 mg tablets
2.2.2 5 mg tablets
2.2.3 10mg tablets
2.2.4 20 mg tablets
2.3 Tadalafil Oral Sales by Type
2.3.1 Global Tadalafil Oral Sales Market Share by Type (2020-2025)
2.3.2 Global Tadalafil Oral Revenue and Market Share by Type (2020-2025)
2.3.3 Global Tadalafil Oral Sale Price by Type (2020-2025)
2.4 Tadalafil Oral Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Tadalafil Oral Sales by Application
2.5.1 Global Tadalafil Oral Sale Market Share by Application (2020-2025)
2.5.2 Global Tadalafil Oral Revenue and Market Share by Application (2020-2025)
2.5.3 Global Tadalafil Oral Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Tadalafil Oral Breakdown Data by Company
3.1.1 Global Tadalafil Oral Annual Sales by Company (2020-2025)
3.1.2 Global Tadalafil Oral Sales Market Share by Company (2020-2025)
3.2 Global Tadalafil Oral Annual Revenue by Company (2020-2025)
3.2.1 Global Tadalafil Oral Revenue by Company (2020-2025)
3.2.2 Global Tadalafil Oral Revenue Market Share by Company (2020-2025)
3.3 Global Tadalafil Oral Sale Price by Company
3.4 Key Manufacturers Tadalafil Oral Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tadalafil Oral Product Location Distribution
3.4.2 Players Tadalafil Oral Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TADALAFIL ORAL BY GEOGRAPHIC REGION
4.1 World Historic Tadalafil Oral Market Size by Geographic Region (2020-2025)
4.1.1 Global Tadalafil Oral Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Tadalafil Oral Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Tadalafil Oral Market Size by Country/Region (2020-2025)
4.2.1 Global Tadalafil Oral Annual Sales by Country/Region (2020-2025)
4.2.2 Global Tadalafil Oral Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tadalafil Oral Sales Growth
4.4 APAC Tadalafil Oral Sales Growth
4.5 Europe Tadalafil Oral Sales Growth
4.6 Middle East & Africa Tadalafil Oral Sales Growth
5 AMERICAS
5.1 Americas Tadalafil Oral Sales by Country
5.1.1 Americas Tadalafil Oral Sales by Country (2020-2025)
5.1.2 Americas Tadalafil Oral Revenue by Country (2020-2025)
5.2 Americas Tadalafil Oral Sales by Type (2020-2025)
5.3 Americas Tadalafil Oral Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tadalafil Oral Sales by Region
6.1.1 APAC Tadalafil Oral Sales by Region (2020-2025)
6.1.2 APAC Tadalafil Oral Revenue by Region (2020-2025)
6.2 APAC Tadalafil Oral Sales by Type (2020-2025)
6.3 APAC Tadalafil Oral Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tadalafil Oral by Country
7.1.1 Europe Tadalafil Oral Sales by Country (2020-2025)
7.1.2 Europe Tadalafil Oral Revenue by Country (2020-2025)
7.2 Europe Tadalafil Oral Sales by Type (2020-2025)
7.3 Europe Tadalafil Oral Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tadalafil Oral by Country
8.1.1 Middle East & Africa Tadalafil Oral Sales by Country (2020-2025)
8.1.2 Middle East & Africa Tadalafil Oral Revenue by Country (2020-2025)
8.2 Middle East & Africa Tadalafil Oral Sales by Type (2020-2025)
8.3 Middle East & Africa Tadalafil Oral Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tadalafil Oral
10.3 Manufacturing Process Analysis of Tadalafil Oral
10.4 Industry Chain Structure of Tadalafil Oral
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tadalafil Oral Distributors
11.3 Tadalafil Oral Customer
12 WORLD FORECAST REVIEW FOR TADALAFIL ORAL BY GEOGRAPHIC REGION
12.1 Global Tadalafil Oral Market Size Forecast by Region
12.1.1 Global Tadalafil Oral Forecast by Region (2026-2031)
12.1.2 Global Tadalafil Oral Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Tadalafil Oral Forecast by Type (2026-2031)
12.7 Global Tadalafil Oral Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Tadalafil Oral Product Portfolios and Specifications
13.1.3 Eli Lilly Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Tadalafil Oral Product Portfolios and Specifications
13.2.3 Teva Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Aurobindo
13.3.1 Aurobindo Company Information
13.3.2 Aurobindo Tadalafil Oral Product Portfolios and Specifications
13.3.3 Aurobindo Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Aurobindo Main Business Overview
13.3.5 Aurobindo Latest Developments
13.4 Sun Pharma
13.4.1 Sun Pharma Company Information
13.4.2 Sun Pharma Tadalafil Oral Product Portfolios and Specifications
13.4.3 Sun Pharma Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sun Pharma Main Business Overview
13.4.5 Sun Pharma Latest Developments
13.5 Alembic Pharmaceuticals
13.5.1 Alembic Pharmaceuticals Company Information
13.5.2 Alembic Pharmaceuticals Tadalafil Oral Product Portfolios and Specifications
13.5.3 Alembic Pharmaceuticals Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Alembic Pharmaceuticals Main Business Overview
13.5.5 Alembic Pharmaceuticals Latest Developments
13.6 Mylan
13.6.1 Mylan Company Information
13.6.2 Mylan Tadalafil Oral Product Portfolios and Specifications
13.6.3 Mylan Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Mylan Main Business Overview
13.6.5 Mylan Latest Developments
13.7 Cipla
13.7.1 Cipla Company Information
13.7.2 Cipla Tadalafil Oral Product Portfolios and Specifications
13.7.3 Cipla Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Cipla Main Business Overview
13.7.5 Cipla Latest Developments
13.8 Ajanta Pharma Ltd.
13.8.1 Ajanta Pharma Ltd. Company Information
13.8.2 Ajanta Pharma Ltd. Tadalafil Oral Product Portfolios and Specifications
13.8.3 Ajanta Pharma Ltd. Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Ajanta Pharma Ltd. Main Business Overview
13.8.5 Ajanta Pharma Ltd. Latest Developments
13.9 Dr. Reddys Laboratories
13.9.1 Dr. Reddys Laboratories Company Information
13.9.2 Dr. Reddys Laboratories Tadalafil Oral Product Portfolios and Specifications
13.9.3 Dr. Reddys Laboratories Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Dr. Reddys Laboratories Main Business Overview
13.9.5 Dr. Reddys Laboratories Latest Developments
13.10 Qilu Pharmaceutical
13.10.1 Qilu Pharmaceutical Company Information
13.10.2 Qilu Pharmaceutical Tadalafil Oral Product Portfolios and Specifications
13.10.3 Qilu Pharmaceutical Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Qilu Pharmaceutical Main Business Overview
13.10.5 Qilu Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Tadalafil Oral Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Tadalafil Oral by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Tadalafil Oral by Country/Region, 2020, 2024 & 2031
2.2 Tadalafil Oral Segment by Type
2.2.1 2.5 mg tablets
2.2.2 5 mg tablets
2.2.3 10mg tablets
2.2.4 20 mg tablets
2.3 Tadalafil Oral Sales by Type
2.3.1 Global Tadalafil Oral Sales Market Share by Type (2020-2025)
2.3.2 Global Tadalafil Oral Revenue and Market Share by Type (2020-2025)
2.3.3 Global Tadalafil Oral Sale Price by Type (2020-2025)
2.4 Tadalafil Oral Segment by Application
2.4.1 Hospital
2.4.2 Drug store
2.5 Tadalafil Oral Sales by Application
2.5.1 Global Tadalafil Oral Sale Market Share by Application (2020-2025)
2.5.2 Global Tadalafil Oral Revenue and Market Share by Application (2020-2025)
2.5.3 Global Tadalafil Oral Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Tadalafil Oral Breakdown Data by Company
3.1.1 Global Tadalafil Oral Annual Sales by Company (2020-2025)
3.1.2 Global Tadalafil Oral Sales Market Share by Company (2020-2025)
3.2 Global Tadalafil Oral Annual Revenue by Company (2020-2025)
3.2.1 Global Tadalafil Oral Revenue by Company (2020-2025)
3.2.2 Global Tadalafil Oral Revenue Market Share by Company (2020-2025)
3.3 Global Tadalafil Oral Sale Price by Company
3.4 Key Manufacturers Tadalafil Oral Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tadalafil Oral Product Location Distribution
3.4.2 Players Tadalafil Oral Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TADALAFIL ORAL BY GEOGRAPHIC REGION
4.1 World Historic Tadalafil Oral Market Size by Geographic Region (2020-2025)
4.1.1 Global Tadalafil Oral Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Tadalafil Oral Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Tadalafil Oral Market Size by Country/Region (2020-2025)
4.2.1 Global Tadalafil Oral Annual Sales by Country/Region (2020-2025)
4.2.2 Global Tadalafil Oral Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tadalafil Oral Sales Growth
4.4 APAC Tadalafil Oral Sales Growth
4.5 Europe Tadalafil Oral Sales Growth
4.6 Middle East & Africa Tadalafil Oral Sales Growth
5 AMERICAS
5.1 Americas Tadalafil Oral Sales by Country
5.1.1 Americas Tadalafil Oral Sales by Country (2020-2025)
5.1.2 Americas Tadalafil Oral Revenue by Country (2020-2025)
5.2 Americas Tadalafil Oral Sales by Type (2020-2025)
5.3 Americas Tadalafil Oral Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tadalafil Oral Sales by Region
6.1.1 APAC Tadalafil Oral Sales by Region (2020-2025)
6.1.2 APAC Tadalafil Oral Revenue by Region (2020-2025)
6.2 APAC Tadalafil Oral Sales by Type (2020-2025)
6.3 APAC Tadalafil Oral Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Tadalafil Oral by Country
7.1.1 Europe Tadalafil Oral Sales by Country (2020-2025)
7.1.2 Europe Tadalafil Oral Revenue by Country (2020-2025)
7.2 Europe Tadalafil Oral Sales by Type (2020-2025)
7.3 Europe Tadalafil Oral Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Tadalafil Oral by Country
8.1.1 Middle East & Africa Tadalafil Oral Sales by Country (2020-2025)
8.1.2 Middle East & Africa Tadalafil Oral Revenue by Country (2020-2025)
8.2 Middle East & Africa Tadalafil Oral Sales by Type (2020-2025)
8.3 Middle East & Africa Tadalafil Oral Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tadalafil Oral
10.3 Manufacturing Process Analysis of Tadalafil Oral
10.4 Industry Chain Structure of Tadalafil Oral
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tadalafil Oral Distributors
11.3 Tadalafil Oral Customer
12 WORLD FORECAST REVIEW FOR TADALAFIL ORAL BY GEOGRAPHIC REGION
12.1 Global Tadalafil Oral Market Size Forecast by Region
12.1.1 Global Tadalafil Oral Forecast by Region (2026-2031)
12.1.2 Global Tadalafil Oral Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Tadalafil Oral Forecast by Type (2026-2031)
12.7 Global Tadalafil Oral Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Eli Lilly
13.1.1 Eli Lilly Company Information
13.1.2 Eli Lilly Tadalafil Oral Product Portfolios and Specifications
13.1.3 Eli Lilly Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Eli Lilly Main Business Overview
13.1.5 Eli Lilly Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Tadalafil Oral Product Portfolios and Specifications
13.2.3 Teva Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Aurobindo
13.3.1 Aurobindo Company Information
13.3.2 Aurobindo Tadalafil Oral Product Portfolios and Specifications
13.3.3 Aurobindo Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Aurobindo Main Business Overview
13.3.5 Aurobindo Latest Developments
13.4 Sun Pharma
13.4.1 Sun Pharma Company Information
13.4.2 Sun Pharma Tadalafil Oral Product Portfolios and Specifications
13.4.3 Sun Pharma Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sun Pharma Main Business Overview
13.4.5 Sun Pharma Latest Developments
13.5 Alembic Pharmaceuticals
13.5.1 Alembic Pharmaceuticals Company Information
13.5.2 Alembic Pharmaceuticals Tadalafil Oral Product Portfolios and Specifications
13.5.3 Alembic Pharmaceuticals Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Alembic Pharmaceuticals Main Business Overview
13.5.5 Alembic Pharmaceuticals Latest Developments
13.6 Mylan
13.6.1 Mylan Company Information
13.6.2 Mylan Tadalafil Oral Product Portfolios and Specifications
13.6.3 Mylan Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Mylan Main Business Overview
13.6.5 Mylan Latest Developments
13.7 Cipla
13.7.1 Cipla Company Information
13.7.2 Cipla Tadalafil Oral Product Portfolios and Specifications
13.7.3 Cipla Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Cipla Main Business Overview
13.7.5 Cipla Latest Developments
13.8 Ajanta Pharma Ltd.
13.8.1 Ajanta Pharma Ltd. Company Information
13.8.2 Ajanta Pharma Ltd. Tadalafil Oral Product Portfolios and Specifications
13.8.3 Ajanta Pharma Ltd. Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Ajanta Pharma Ltd. Main Business Overview
13.8.5 Ajanta Pharma Ltd. Latest Developments
13.9 Dr. Reddys Laboratories
13.9.1 Dr. Reddys Laboratories Company Information
13.9.2 Dr. Reddys Laboratories Tadalafil Oral Product Portfolios and Specifications
13.9.3 Dr. Reddys Laboratories Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Dr. Reddys Laboratories Main Business Overview
13.9.5 Dr. Reddys Laboratories Latest Developments
13.10 Qilu Pharmaceutical
13.10.1 Qilu Pharmaceutical Company Information
13.10.2 Qilu Pharmaceutical Tadalafil Oral Product Portfolios and Specifications
13.10.3 Qilu Pharmaceutical Tadalafil Oral Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Qilu Pharmaceutical Main Business Overview
13.10.5 Qilu Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Tadalafil Oral Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Tadalafil Oral Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 2.5 mg tablets
Table 4. Major Players of 5 mg tablets
Table 5. Major Players of 10mg tablets
Table 6. Major Players of 20 mg tablets
Table 7. Global Tadalafil Oral Sales by Type (2020-2025) & (K Units)
Table 8. Global Tadalafil Oral Sales Market Share by Type (2020-2025)
Table 9. Global Tadalafil Oral Revenue by Type (2020-2025) & ($ million)
Table 10. Global Tadalafil Oral Revenue Market Share by Type (2020-2025)
Table 11. Global Tadalafil Oral Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Tadalafil Oral Sale by Application (2020-2025) & (K Units)
Table 13. Global Tadalafil Oral Sale Market Share by Application (2020-2025)
Table 14. Global Tadalafil Oral Revenue by Application (2020-2025) & ($ million)
Table 15. Global Tadalafil Oral Revenue Market Share by Application (2020-2025)
Table 16. Global Tadalafil Oral Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Tadalafil Oral Sales by Company (2020-2025) & (K Units)
Table 18. Global Tadalafil Oral Sales Market Share by Company (2020-2025)
Table 19. Global Tadalafil Oral Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Tadalafil Oral Revenue Market Share by Company (2020-2025)
Table 21. Global Tadalafil Oral Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Tadalafil Oral Producing Area Distribution and Sales Area
Table 23. Players Tadalafil Oral Products Offered
Table 24. Tadalafil Oral Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Tadalafil Oral Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Tadalafil Oral Sales Market Share Geographic Region (2020-2025)
Table 29. Global Tadalafil Oral Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Tadalafil Oral Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Tadalafil Oral Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Tadalafil Oral Sales Market Share by Country/Region (2020-2025)
Table 33. Global Tadalafil Oral Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Tadalafil Oral Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Tadalafil Oral Sales by Country (2020-2025) & (K Units)
Table 36. Americas Tadalafil Oral Sales Market Share by Country (2020-2025)
Table 37. Americas Tadalafil Oral Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Tadalafil Oral Sales by Type (2020-2025) & (K Units)
Table 39. Americas Tadalafil Oral Sales by Application (2020-2025) & (K Units)
Table 40. APAC Tadalafil Oral Sales by Region (2020-2025) & (K Units)
Table 41. APAC Tadalafil Oral Sales Market Share by Region (2020-2025)
Table 42. APAC Tadalafil Oral Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Tadalafil Oral Sales by Type (2020-2025) & (K Units)
Table 44. APAC Tadalafil Oral Sales by Application (2020-2025) & (K Units)
Table 45. Europe Tadalafil Oral Sales by Country (2020-2025) & (K Units)
Table 46. Europe Tadalafil Oral Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Tadalafil Oral Sales by Type (2020-2025) & (K Units)
Table 48. Europe Tadalafil Oral Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Tadalafil Oral Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Tadalafil Oral Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Tadalafil Oral Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Tadalafil Oral Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Tadalafil Oral
Table 54. Key Market Challenges & Risks of Tadalafil Oral
Table 55. Key Industry Trends of Tadalafil Oral
Table 56. Tadalafil Oral Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Tadalafil Oral Distributors List
Table 59. Tadalafil Oral Customer List
Table 60. Global Tadalafil Oral Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Tadalafil Oral Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Tadalafil Oral Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Tadalafil Oral Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Tadalafil Oral Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Tadalafil Oral Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Tadalafil Oral Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Tadalafil Oral Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Tadalafil Oral Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Tadalafil Oral Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Tadalafil Oral Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Tadalafil Oral Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Tadalafil Oral Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Tadalafil Oral Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Eli Lilly Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 75. Eli Lilly Tadalafil Oral Product Portfolios and Specifications
Table 76. Eli Lilly Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Eli Lilly Main Business
Table 78. Eli Lilly Latest Developments
Table 79. Teva Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 80. Teva Tadalafil Oral Product Portfolios and Specifications
Table 81. Teva Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Teva Main Business
Table 83. Teva Latest Developments
Table 84. Aurobindo Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 85. Aurobindo Tadalafil Oral Product Portfolios and Specifications
Table 86. Aurobindo Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Aurobindo Main Business
Table 88. Aurobindo Latest Developments
Table 89. Sun Pharma Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 90. Sun Pharma Tadalafil Oral Product Portfolios and Specifications
Table 91. Sun Pharma Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Sun Pharma Main Business
Table 93. Sun Pharma Latest Developments
Table 94. Alembic Pharmaceuticals Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 95. Alembic Pharmaceuticals Tadalafil Oral Product Portfolios and Specifications
Table 96. Alembic Pharmaceuticals Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Alembic Pharmaceuticals Main Business
Table 98. Alembic Pharmaceuticals Latest Developments
Table 99. Mylan Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 100. Mylan Tadalafil Oral Product Portfolios and Specifications
Table 101. Mylan Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Mylan Main Business
Table 103. Mylan Latest Developments
Table 104. Cipla Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 105. Cipla Tadalafil Oral Product Portfolios and Specifications
Table 106. Cipla Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Cipla Main Business
Table 108. Cipla Latest Developments
Table 109. Ajanta Pharma Ltd. Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 110. Ajanta Pharma Ltd. Tadalafil Oral Product Portfolios and Specifications
Table 111. Ajanta Pharma Ltd. Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Ajanta Pharma Ltd. Main Business
Table 113. Ajanta Pharma Ltd. Latest Developments
Table 114. Dr. Reddys Laboratories Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 115. Dr. Reddys Laboratories Tadalafil Oral Product Portfolios and Specifications
Table 116. Dr. Reddys Laboratories Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Dr. Reddys Laboratories Main Business
Table 118. Dr. Reddys Laboratories Latest Developments
Table 119. Qilu Pharmaceutical Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 120. Qilu Pharmaceutical Tadalafil Oral Product Portfolios and Specifications
Table 121. Qilu Pharmaceutical Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Qilu Pharmaceutical Main Business
Table 123. Qilu Pharmaceutical Latest Developments
Table 1. Tadalafil Oral Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Tadalafil Oral Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 2.5 mg tablets
Table 4. Major Players of 5 mg tablets
Table 5. Major Players of 10mg tablets
Table 6. Major Players of 20 mg tablets
Table 7. Global Tadalafil Oral Sales by Type (2020-2025) & (K Units)
Table 8. Global Tadalafil Oral Sales Market Share by Type (2020-2025)
Table 9. Global Tadalafil Oral Revenue by Type (2020-2025) & ($ million)
Table 10. Global Tadalafil Oral Revenue Market Share by Type (2020-2025)
Table 11. Global Tadalafil Oral Sale Price by Type (2020-2025) & (USD/Unit)
Table 12. Global Tadalafil Oral Sale by Application (2020-2025) & (K Units)
Table 13. Global Tadalafil Oral Sale Market Share by Application (2020-2025)
Table 14. Global Tadalafil Oral Revenue by Application (2020-2025) & ($ million)
Table 15. Global Tadalafil Oral Revenue Market Share by Application (2020-2025)
Table 16. Global Tadalafil Oral Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Tadalafil Oral Sales by Company (2020-2025) & (K Units)
Table 18. Global Tadalafil Oral Sales Market Share by Company (2020-2025)
Table 19. Global Tadalafil Oral Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Tadalafil Oral Revenue Market Share by Company (2020-2025)
Table 21. Global Tadalafil Oral Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Tadalafil Oral Producing Area Distribution and Sales Area
Table 23. Players Tadalafil Oral Products Offered
Table 24. Tadalafil Oral Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Tadalafil Oral Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Tadalafil Oral Sales Market Share Geographic Region (2020-2025)
Table 29. Global Tadalafil Oral Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Tadalafil Oral Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Tadalafil Oral Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Tadalafil Oral Sales Market Share by Country/Region (2020-2025)
Table 33. Global Tadalafil Oral Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Tadalafil Oral Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Tadalafil Oral Sales by Country (2020-2025) & (K Units)
Table 36. Americas Tadalafil Oral Sales Market Share by Country (2020-2025)
Table 37. Americas Tadalafil Oral Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Tadalafil Oral Sales by Type (2020-2025) & (K Units)
Table 39. Americas Tadalafil Oral Sales by Application (2020-2025) & (K Units)
Table 40. APAC Tadalafil Oral Sales by Region (2020-2025) & (K Units)
Table 41. APAC Tadalafil Oral Sales Market Share by Region (2020-2025)
Table 42. APAC Tadalafil Oral Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Tadalafil Oral Sales by Type (2020-2025) & (K Units)
Table 44. APAC Tadalafil Oral Sales by Application (2020-2025) & (K Units)
Table 45. Europe Tadalafil Oral Sales by Country (2020-2025) & (K Units)
Table 46. Europe Tadalafil Oral Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Tadalafil Oral Sales by Type (2020-2025) & (K Units)
Table 48. Europe Tadalafil Oral Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Tadalafil Oral Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Tadalafil Oral Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Tadalafil Oral Sales by Type (2020-2025) & (K Units)
Table 52. Middle East & Africa Tadalafil Oral Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Tadalafil Oral
Table 54. Key Market Challenges & Risks of Tadalafil Oral
Table 55. Key Industry Trends of Tadalafil Oral
Table 56. Tadalafil Oral Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Tadalafil Oral Distributors List
Table 59. Tadalafil Oral Customer List
Table 60. Global Tadalafil Oral Sales Forecast by Region (2026-2031) & (K Units)
Table 61. Global Tadalafil Oral Revenue Forecast by Region (2026-2031) & ($ millions)
Table 62. Americas Tadalafil Oral Sales Forecast by Country (2026-2031) & (K Units)
Table 63. Americas Tadalafil Oral Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 64. APAC Tadalafil Oral Sales Forecast by Region (2026-2031) & (K Units)
Table 65. APAC Tadalafil Oral Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 66. Europe Tadalafil Oral Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Europe Tadalafil Oral Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Tadalafil Oral Sales Forecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Tadalafil Oral Revenue Forecast by Country (2026-2031) & ($ millions)
Table 70. Global Tadalafil Oral Sales Forecast by Type (2026-2031) & (K Units)
Table 71. Global Tadalafil Oral Revenue Forecast by Type (2026-2031) & ($ millions)
Table 72. Global Tadalafil Oral Sales Forecast by Application (2026-2031) & (K Units)
Table 73. Global Tadalafil Oral Revenue Forecast by Application (2026-2031) & ($ millions)
Table 74. Eli Lilly Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 75. Eli Lilly Tadalafil Oral Product Portfolios and Specifications
Table 76. Eli Lilly Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Eli Lilly Main Business
Table 78. Eli Lilly Latest Developments
Table 79. Teva Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 80. Teva Tadalafil Oral Product Portfolios and Specifications
Table 81. Teva Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Teva Main Business
Table 83. Teva Latest Developments
Table 84. Aurobindo Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 85. Aurobindo Tadalafil Oral Product Portfolios and Specifications
Table 86. Aurobindo Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Aurobindo Main Business
Table 88. Aurobindo Latest Developments
Table 89. Sun Pharma Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 90. Sun Pharma Tadalafil Oral Product Portfolios and Specifications
Table 91. Sun Pharma Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Sun Pharma Main Business
Table 93. Sun Pharma Latest Developments
Table 94. Alembic Pharmaceuticals Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 95. Alembic Pharmaceuticals Tadalafil Oral Product Portfolios and Specifications
Table 96. Alembic Pharmaceuticals Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Alembic Pharmaceuticals Main Business
Table 98. Alembic Pharmaceuticals Latest Developments
Table 99. Mylan Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 100. Mylan Tadalafil Oral Product Portfolios and Specifications
Table 101. Mylan Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Mylan Main Business
Table 103. Mylan Latest Developments
Table 104. Cipla Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 105. Cipla Tadalafil Oral Product Portfolios and Specifications
Table 106. Cipla Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Cipla Main Business
Table 108. Cipla Latest Developments
Table 109. Ajanta Pharma Ltd. Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 110. Ajanta Pharma Ltd. Tadalafil Oral Product Portfolios and Specifications
Table 111. Ajanta Pharma Ltd. Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Ajanta Pharma Ltd. Main Business
Table 113. Ajanta Pharma Ltd. Latest Developments
Table 114. Dr. Reddys Laboratories Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 115. Dr. Reddys Laboratories Tadalafil Oral Product Portfolios and Specifications
Table 116. Dr. Reddys Laboratories Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Dr. Reddys Laboratories Main Business
Table 118. Dr. Reddys Laboratories Latest Developments
Table 119. Qilu Pharmaceutical Basic Information, Tadalafil Oral Manufacturing Base, Sales Area and Its Competitors
Table 120. Qilu Pharmaceutical Tadalafil Oral Product Portfolios and Specifications
Table 121. Qilu Pharmaceutical Tadalafil Oral Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Qilu Pharmaceutical Main Business
Table 123. Qilu Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Tadalafil Oral
Figure 2. Tadalafil Oral Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tadalafil Oral Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Tadalafil Oral Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Tadalafil Oral Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Tadalafil Oral Sales Market Share by Country/Region (2024)
Figure 10. Tadalafil Oral Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 2.5 mg tablets
Figure 12. Product Picture of 5 mg tablets
Figure 13. Product Picture of 10mg tablets
Figure 14. Product Picture of 20 mg tablets
Figure 15. Global Tadalafil Oral Sales Market Share by Type in 2025
Figure 16. Global Tadalafil Oral Revenue Market Share by Type (2020-2025)
Figure 17. Tadalafil Oral Consumed in Hospital
Figure 18. Global Tadalafil Oral Market: Hospital (2020-2025) & (K Units)
Figure 19. Tadalafil Oral Consumed in Drug store
Figure 20. Global Tadalafil Oral Market: Drug store (2020-2025) & (K Units)
Figure 21. Global Tadalafil Oral Sale Market Share by Application (2024)
Figure 22. Global Tadalafil Oral Revenue Market Share by Application in 2025
Figure 23. Tadalafil Oral Sales by Company in 2025 (K Units)
Figure 24. Global Tadalafil Oral Sales Market Share by Company in 2025
Figure 25. Tadalafil Oral Revenue by Company in 2025 ($ millions)
Figure 26. Global Tadalafil Oral Revenue Market Share by Company in 2025
Figure 27. Global Tadalafil Oral Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Tadalafil Oral Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Tadalafil Oral Sales 2020-2025 (K Units)
Figure 30. Americas Tadalafil Oral Revenue 2020-2025 ($ millions)
Figure 31. APAC Tadalafil Oral Sales 2020-2025 (K Units)
Figure 32. APAC Tadalafil Oral Revenue 2020-2025 ($ millions)
Figure 33. Europe Tadalafil Oral Sales 2020-2025 (K Units)
Figure 34. Europe Tadalafil Oral Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Tadalafil Oral Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Tadalafil Oral Revenue 2020-2025 ($ millions)
Figure 37. Americas Tadalafil Oral Sales Market Share by Country in 2025
Figure 38. Americas Tadalafil Oral Revenue Market Share by Country (2020-2025)
Figure 39. Americas Tadalafil Oral Sales Market Share by Type (2020-2025)
Figure 40. Americas Tadalafil Oral Sales Market Share by Application (2020-2025)
Figure 41. United States Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Tadalafil Oral Sales Market Share by Region in 2025
Figure 46. APAC Tadalafil Oral Revenue Market Share by Region (2020-2025)
Figure 47. APAC Tadalafil Oral Sales Market Share by Type (2020-2025)
Figure 48. APAC Tadalafil Oral Sales Market Share by Application (2020-2025)
Figure 49. China Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 53. India Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Tadalafil Oral Sales Market Share by Country in 2025
Figure 57. Europe Tadalafil Oral Revenue Market Share by Country (2020-2025)
Figure 58. Europe Tadalafil Oral Sales Market Share by Type (2020-2025)
Figure 59. Europe Tadalafil Oral Sales Market Share by Application (2020-2025)
Figure 60. Germany Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 61. France Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Tadalafil Oral Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Tadalafil Oral Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Tadalafil Oral Sales Market Share by Application (2020-2025)
Figure 68. Egypt Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Tadalafil Oral in 2025
Figure 74. Manufacturing Process Analysis of Tadalafil Oral
Figure 75. Industry Chain Structure of Tadalafil Oral
Figure 76. Channels of Distribution
Figure 77. Global Tadalafil Oral Sales Market Forecast by Region (2026-2031)
Figure 78. Global Tadalafil Oral Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Tadalafil Oral Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Tadalafil Oral Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Tadalafil Oral Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Tadalafil Oral Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Tadalafil Oral
Figure 2. Tadalafil Oral Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tadalafil Oral Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Tadalafil Oral Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Tadalafil Oral Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Tadalafil Oral Sales Market Share by Country/Region (2024)
Figure 10. Tadalafil Oral Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 2.5 mg tablets
Figure 12. Product Picture of 5 mg tablets
Figure 13. Product Picture of 10mg tablets
Figure 14. Product Picture of 20 mg tablets
Figure 15. Global Tadalafil Oral Sales Market Share by Type in 2025
Figure 16. Global Tadalafil Oral Revenue Market Share by Type (2020-2025)
Figure 17. Tadalafil Oral Consumed in Hospital
Figure 18. Global Tadalafil Oral Market: Hospital (2020-2025) & (K Units)
Figure 19. Tadalafil Oral Consumed in Drug store
Figure 20. Global Tadalafil Oral Market: Drug store (2020-2025) & (K Units)
Figure 21. Global Tadalafil Oral Sale Market Share by Application (2024)
Figure 22. Global Tadalafil Oral Revenue Market Share by Application in 2025
Figure 23. Tadalafil Oral Sales by Company in 2025 (K Units)
Figure 24. Global Tadalafil Oral Sales Market Share by Company in 2025
Figure 25. Tadalafil Oral Revenue by Company in 2025 ($ millions)
Figure 26. Global Tadalafil Oral Revenue Market Share by Company in 2025
Figure 27. Global Tadalafil Oral Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global Tadalafil Oral Revenue Market Share by Geographic Region in 2025
Figure 29. Americas Tadalafil Oral Sales 2020-2025 (K Units)
Figure 30. Americas Tadalafil Oral Revenue 2020-2025 ($ millions)
Figure 31. APAC Tadalafil Oral Sales 2020-2025 (K Units)
Figure 32. APAC Tadalafil Oral Revenue 2020-2025 ($ millions)
Figure 33. Europe Tadalafil Oral Sales 2020-2025 (K Units)
Figure 34. Europe Tadalafil Oral Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa Tadalafil Oral Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa Tadalafil Oral Revenue 2020-2025 ($ millions)
Figure 37. Americas Tadalafil Oral Sales Market Share by Country in 2025
Figure 38. Americas Tadalafil Oral Revenue Market Share by Country (2020-2025)
Figure 39. Americas Tadalafil Oral Sales Market Share by Type (2020-2025)
Figure 40. Americas Tadalafil Oral Sales Market Share by Application (2020-2025)
Figure 41. United States Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC Tadalafil Oral Sales Market Share by Region in 2025
Figure 46. APAC Tadalafil Oral Revenue Market Share by Region (2020-2025)
Figure 47. APAC Tadalafil Oral Sales Market Share by Type (2020-2025)
Figure 48. APAC Tadalafil Oral Sales Market Share by Application (2020-2025)
Figure 49. China Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 53. India Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 55. China Taiwan Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe Tadalafil Oral Sales Market Share by Country in 2025
Figure 57. Europe Tadalafil Oral Revenue Market Share by Country (2020-2025)
Figure 58. Europe Tadalafil Oral Sales Market Share by Type (2020-2025)
Figure 59. Europe Tadalafil Oral Sales Market Share by Application (2020-2025)
Figure 60. Germany Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 61. France Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 62. UK Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa Tadalafil Oral Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa Tadalafil Oral Sales Market Share by Type (2020-2025)
Figure 67. Middle East & Africa Tadalafil Oral Sales Market Share by Application (2020-2025)
Figure 68. Egypt Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 71. Turkey Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries Tadalafil Oral Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Tadalafil Oral in 2025
Figure 74. Manufacturing Process Analysis of Tadalafil Oral
Figure 75. Industry Chain Structure of Tadalafil Oral
Figure 76. Channels of Distribution
Figure 77. Global Tadalafil Oral Sales Market Forecast by Region (2026-2031)
Figure 78. Global Tadalafil Oral Revenue Market Share Forecast by Region (2026-2031)
Figure 79. Global Tadalafil Oral Sales Market Share Forecast by Type (2026-2031)
Figure 80. Global Tadalafil Oral Revenue Market Share Forecast by Type (2026-2031)
Figure 81. Global Tadalafil Oral Sales Market Share Forecast by Application (2026-2031)
Figure 82. Global Tadalafil Oral Revenue Market Share Forecast by Application (2026-2031)
